KCNA1 expression and site specific DNA methylation in thyroid cancer
Background KCNA1 encodes the voltage-gated potassium channel Kv1.1 and has been implicated in thyroid cancer. Its relationship with DNA methylation and tissue composition remains incompletely understood. Methods TCGA-THCA expression profiles from 505 primary tumors and 59 normal samples and methylation profiles from 507 tumors and 56 normal samples were analyzed using limma. KCNA1 expression was assessed in GSE33630, TPC-1 cells, and xenograft tissues. Clinical associations, receiver operating characteristic curves, CpG-specific methylation, functional enrichment, and immune signatures were examined. ESTIMATE-based stratification and thyroid differentiation scores were used to assess tissue composition, and CpG-expression associations were tested within tumors with and without purity adjustment. Results The analysis identified 2,538 differentially expressed genes and 15,261 differentially methylated probes. KCNA1 expression was lower in TCGA tumors (log2FC = -4.680; adjusted P = 1.73 × 10 -67 ), whereas the difference in GSE33630 was not significant (log2FC = -0.0736; adjusted P = 0.108). Lower expression was also observed in TPC-1 cells and xenograft tissues. Within TCGA tumors, KCNA1 correlated negatively with the ESTIMATE-derived purity score (rho = -0.263) and positively with thyroid differentiation (rho = 0.356). Expression remained lower than normal thyroid in the highest purity quartile (P = 1.67 × 10 -25 ). Among 25 KCNA1 CpGs, the hypomethylated 3′UTR site cg22669120 correlated positively with expression. Inverse associations at cg06204922 and cg20392607 were no longer significant after purity adjustment and correction for multiple testing. Conclusion KCNA1 downregulation in TCGA-THCA is accompanied by heterogeneous CpG-specific methylation patterns and variation in tissue composition. The nonsignificant external expression result and attenuation of promoter-related associations indicate that the relationship between KCNA1 methylation and expression requires further investigation.
Authors
- Li Lv (ORCID: https://orcid.org/0000-0002-2132-6558)
- Chengfei Wang (ORCID: https://orcid.org/0009-0005-2498-9284)
- Yangbo Kang
- Qi Yang (ORCID: https://orcid.org/0000-0002-8149-2937)
- Yunyi Ding
- Xiaoying Chen
- Yongan Xu
- Xu Wang
- Li Hong
Institutions
- Guizhou University of Traditional Chinese Medicine (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-11-20
- DOI
- https://doi.org/10.3389/fonc.2026.1994182
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00